Authors
Loading...
Techno-economic modeling reveals key cost drivers and scale-up bottlenecks in biosynthetic human insulin manufacturing, highlighting pathways for cost and environmental impact reduction.
Petrides et al. (1995) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: